LLY vs JNJ
By Alex · Tickerpine
Eli Lilly and Company vs Johnson & Johnson, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | JNJ |
|---|---|---|
| Price | $1,208.12 | $254.66 |
| Market cap | $1.08T | $613.02B |
| P/E ratio | 42.9 | 29.5 |
| ROE | 107.46% | 26.42% |
| Profit margin | 34.99% | 21.83% |
| Revenue growth | 55.50% | 9.90% |
| Dividend yield | 0.57% | 2.10% |
| Beta | 0.52 | 0.26 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs JNJ in plain English
- LLY is the bigger company — about 1.8× the market cap of JNJ.
- JNJ is cheaper on earnings (P/E 29.5 vs 42.9).
- LLY earns a higher return on equity (107% vs 26%).
- LLY is growing revenue faster (56% vs 10%).
- JNJ has the higher dividend yield (2.10% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.